Buy & Sell Abeona Therapeutics Inc (ABEO) – Abeona Therapeutics Inc Price Today
Aura AI Summary
Key Stats
- $324.59MMarket Cap
- HealthSector
- -18.02%3M Drawdown
- $179.49MEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 9 daysTypical Hold Time
Abeona Therapeutics Inc (ABEO) is currently valued at a market capitalization of $324.59M, with an enterprise value of $179.49M. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.23, highlighting its annual price range. Over the past three months, Abeona Therapeutics Inc has recorded a drawdown of -18.02%, reflecting recent price volatility. On average, investors hold Abeona Therapeutics Inc for approximately 9 days, indicating typical investor behavior on the platform.
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Most Recent News
Wound irrigation systems market to grow to $430M by 2035, driven by rising chronic wounds and surgeries.
The global wound irrigation systems market, valued at $307.87 million in 2025, is projected to reach $430.05 million by 2035 with a CAGR of 3.55%. Growth is fueled by increasing chronic wound cases, more surgeries, and rising diabetes and obesity rat...

Vertiv declares quarterly dividend of $0.0625 per share payable June 25, 2026.
Vertiv Holdings Co announced a quarterly cash dividend of $0.0625 per share for its Class A common stock. The dividend will be paid on June 25, 2026, to shareholders recorded by June 15, 2026. Vertiv is a global leader in critical digital infrastruct...

Mastercard appoints Ling Hai as CFO amid leadership reshuffle and faces weak stock momentum.
Mastercard announced a leadership reshuffle effective August 3, with Ling Hai, president of Asia Pacific, Europe, Middle East, and Africa, named as the new CFO, replacing Sachin Mehra who will become chief business officer. Other leadership changes i...
